AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients 23 Apr 2022 Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to new research. Find out more Show/Hide
AACR 2022: New 'killer' immunotherapy shows early promise in range of solid tumours 08 Apr 2022 A new type of immunotherapy making use of the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest. Find out more Show/Hide
AI test could predict effective cancer drug combinations in less than two days 04 Apr 2022 Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours. Find out more Show/Hide
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy 09 Mar 2019